Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2024 Earnings Call Transcript
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2024 Earnings Call Transcript March 3, 2025Ocular Therapeutix, Inc. misses on earnings expectations.
Posts Tagged ‘NASDAQ:OCUL’
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Ocular Therapeutix Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Ocular Therapeutix second-quarter 2024 earnings conference call. [Operator Instructions].
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2023 Earnings Call Transcript
Operator: Good day. Thank you for standing by. Welcome to the Third Quarter 2023 Ocular Therapeutix Earnings Conference Call.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Quarter 2023 Ocular Therapeutics Earnings Conference Call.
10 Best Rising Penny Stocks to Buy
Amid too much volatility everyone seems to avoid small companies that are working on disruptive products or services which are yet to show their true effects or results.
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Ocular Therapeutics First Quarter 2023 Earnings Conference Call. .
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ocular Therapeutix Fourth Quarter and Year-End 2022 Earnings Conference Call.
Hedge Funds Are Crazy About Ocular Therapeutix Inc (OCUL)
With the second-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Hedge Funds Have Never Been This Bullish On Ocular Therapeutix Inc (OCUL)
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is OCUL A Good Stock To Buy Now?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Should You Avoid Ocular Therapeutix Inc (OCUL)?
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Did Hedge Funds Drop The Ball On Ocular Therapeutix Inc (OCUL) ?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Chevron, Sprint, Ocular Therapeutix, and More: Why These Stocks Are in the Spotlight
All eyes are on the tech sector after President Trump escalated the trade war with China by putting Chinese crown jewel Huawei on a blacklist.
Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study
Positive results for the Phase III study meant to test the experiences of patients using the eye insert known as Dextenza to relieve pain in a post-surgical situation have been...
Biotech Movers And Shakers: Ocular Therapeutix Inc (OCUL) And Argos Therapeutics Inc (ARGS)
The biotechnology space has been a pretty volatile arena over the last few weeks, and especially when it comes to the smaller capitalization end of the sector.
How Ocular Therapeutix Inc (OCUL) Stacks Up Against Its Peers
A whopping number of 13F filings filed with U.S.
Here’s Why Amazon, Alphabet, Ocular Therapeutix, and Two Other Stocks Are Trending on Thursday
In this article, we will analyze the latest events surrounding Amazon.com, Inc.
Why Adamis Pharmaceuticals, Immunomedics and Three Other Stocks Are Deep in Red Today?
Markets are trading higher on Monday, as HSBC Holdings PLC said in a report earlier today that the markets are poised to remain bullish.
David Lamond’s Top Healthcare and Technology Stock Picks
Founded in 2011, David Lamond's Lamond Capital Partners filed its first 13F form in 2012, when it held nearly $110 million in assets under management.
